152 related articles for article (PubMed ID: 18583619)
1. Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters.
Ohkawa R; Nakamura K; Okubo S; Hosogaya S; Ozaki Y; Tozuka M; Osima N; Yokota H; Ikeda H; Yatomi Y
Ann Clin Biochem; 2008 Jul; 45(Pt 4):356-63. PubMed ID: 18583619
[TBL] [Abstract][Full Text] [Related]
2. [Elucidation of the functional roles of lysophospholipid mediators and its application in laboratory medicine].
Yatomi Y
Rinsho Byori; 2006 Jul; 54(7):720-31. PubMed ID: 16913663
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C.
Ikeda H; Ohkawa R; Watanabe N; Nakamura K; Kume Y; Nakagawa H; Yoshida H; Okubo S; Yokota H; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Koike K; Yatomi Y
Clin Chim Acta; 2010 May; 411(9-10):765-70. PubMed ID: 20188085
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine 1-phosphate is a blood constituent released from activated platelets, possibly playing a variety of physiological and pathophysiological roles.
Igarashi Y; Yatomi Y
Acta Biochim Pol; 1998; 45(2):299-309. PubMed ID: 9821862
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration.
Ono Y; Kurano M; Ohkawa R; Yokota H; Igarashi K; Aoki J; Tozuka M; Yatomi Y
Lipids Health Dis; 2013 Feb; 12():20. PubMed ID: 23418753
[TBL] [Abstract][Full Text] [Related]
6. Plasma sphingosine 1-phosphate metabolism and analysis.
Yatomi Y
Biochim Biophys Acta; 2008 Mar; 1780(3):606-11. PubMed ID: 17980708
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine 1-phosphate-related metabolism in the blood vessel.
Aoki S; Yatomi Y; Ohta M; Osada M; Kazama F; Satoh K; Nakahara K; Ozaki Y
J Biochem; 2005 Jul; 138(1):47-55. PubMed ID: 16046448
[TBL] [Abstract][Full Text] [Related]
8. Involvement of sphingosine 1-phosphate, a platelet-derived bioactive lipid, in contraction of mesangium cells.
Osada M; Yatomi Y; Ohmori T; Aoki S; Hosogaya S; Ozaki Y
J Biochem; 2007 Sep; 142(3):351-5. PubMed ID: 17646176
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine 1-phosphate breakdown in platelets.
Yatomi Y; Yamamura S; Hisano N; Nakahara K; Igarashi Y; Ozaki Y
J Biochem; 2004 Oct; 136(4):495-502. PubMed ID: 15625319
[TBL] [Abstract][Full Text] [Related]
10. Plasma sphingosine-1-phosphate concentration is reduced in patients with myocardial infarction.
Knapp M; Baranowski M; Czarnowski D; Lisowska A; Zabielski P; Górski J; Musiał W
Med Sci Monit; 2009 Sep; 15(9):CR490-3. PubMed ID: 19721401
[TBL] [Abstract][Full Text] [Related]
11. Preanalytical standardization of sphingosine-1-phosphate, sphinganine-1-phosphate and sphingosine analysis in human plasma by liquid chromatography-tandem mass spectrometry.
Ceglarek U; Dittrich J; Helmschrodt C; Wagner K; Nofer JR; Thiery J; Becker S
Clin Chim Acta; 2014 Aug; 435():1-6. PubMed ID: 24768784
[TBL] [Abstract][Full Text] [Related]
12. Fluid shear stress enhances the sphingosine 1-phosphate responses in cell-cell interactions between platelets and endothelial cells.
Aoki S; Osada M; Kaneko M; Ozaki Y; Yatomi Y
Biochem Biophys Res Commun; 2007 Jul; 358(4):1054-7. PubMed ID: 17512899
[TBL] [Abstract][Full Text] [Related]
13. Analytical evaluation of plasma serotonin and sphingosine 1-phosphate and their clinical assessment in early atherosclerosis.
Sugiura T; Dohi Y; Yamashita S; Ohte N; Ito S; Iwaki S; Hirowatari Y; Ohkawa R; Mishima Y; Yatomi Y; Kimura G; Fujii S
Coron Artery Dis; 2012 Jun; 23(4):234-8. PubMed ID: 22356865
[TBL] [Abstract][Full Text] [Related]
14. A high-performance liquid chromatographic method to measure sphingosine 1-phosphate and related compounds from sphingosine kinase assays and other biological samples.
Caligan TB; Peters K; Ou J; Wang E; Saba J; Merrill AH
Anal Biochem; 2000 May; 281(1):36-44. PubMed ID: 10847608
[TBL] [Abstract][Full Text] [Related]
15. Regulation by sphingolipids of the fate of FRTL-5 cells.
Satoh Y; Li X; Yokota H; Osada M; Ozaki Y; Katoh R; Yatomi Y
J Biochem; 2009 Jan; 145(1):31-6. PubMed ID: 18953023
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases.
Yatomi Y
Curr Pharm Des; 2006; 12(5):575-87. PubMed ID: 16472149
[TBL] [Abstract][Full Text] [Related]
17. [Sphingolipids, possible biomarkers for atherosclerotic disorders].
Ohkawa R; Kurano M; Nakamura K; Okubo S; Yokota H; Ikeda H; Yatomi Y
Rinsho Byori; 2013 Sep; 61(9):795-802. PubMed ID: 24369591
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine 1-phosphate: synthesis and release.
Yatomi Y; Ozaki Y; Ohmori T; Igarashi Y
Prostaglandins Other Lipid Mediat; 2001 Apr; 64(1-4):107-22. PubMed ID: 11324700
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum.
Yatomi Y; Igarashi Y; Yang L; Hisano N; Qi R; Asazuma N; Satoh K; Ozaki Y; Kume S
J Biochem; 1997 May; 121(5):969-73. PubMed ID: 9192741
[TBL] [Abstract][Full Text] [Related]
20. Quantitative measurement of sphingosine 1-phosphate in biological samples by acylation with radioactive acetic anhydride.
Yatomi Y; Ruan F; Ohta J; Welch RJ; Hakomori S; Igarashi Y
Anal Biochem; 1995 Sep; 230(2):315-20. PubMed ID: 7503424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
